Category:
Active Pharmaceutical Ingredients
CAS NO:
1025967-78-5
Standard:
USP,JP,
Lifitegrast reduces ocular surface inflammation by antagonism of LFA-1 and is indicated for the treatment of signs and symptoms of DED
Lifitegrast is a small molecule integrin antagonist developed for ophthalmic use. Its core synthesis involves complex organic coupling to achieve high purity. The compound features the molecular formula C28H34N6O5S2 and carries CAS number 1079668-46-6.
Contraindicated in patients with known hypersensitivity to the active substance. Requires storage below 25°C in original packaging to maintain chemical stability. Clinical use mandates monitoring for local ocular reactions such as dysgeusia or conjunctival hyperemia.